• MRNA COVID-19 vaccines effective in patients with MS on disease-modifying therapies

    1 month ago - By Healio

    Messenger RNA COVID-19 vaccination was effective among most patients with MS who used various disease-modifying therapies, according to study results published in Neurology.
    However, the extent of protection appeared to differ based on the medication used.
    “Our study aimed to focus on patients with MS, representatives of part of the population with an overall increased risk for serious COVID-19 outcome compared with healthy individuals, due to the treatment with different immunomodulatory or immunosuppressive medications,” Delia Goletti, MD, PhD, of the Translational Research Unit
    Read more ...

     

  • Shared Decision Making and Disease Modifying Therapy in Families of Children and Adolescents with Pediatric Onset Multiple Sclerosis

    Shared Decision Making and Disease Modifying Therapy in Families of Children and Adolescents with Pediatric Onset Multiple Sclerosis

    1 month ago - By Journal of Pediatric Nursing

    Deciding on a disease modifying therapy for the treatment of pediatric onset multiple sclerosis often presents a challenge to families. Parents are often overwhelmed by DMT choices, but they desire to be an integral part of the decision making process for their child. There is no standard approach for how best to involve families in this process. The aim of this study was to describe the experience of decision making related to the use of disease modifying therapy in parents of children and adolescents with POMS.
    Read more ...